How will GSK’s consumer health business go solo? A talk with the Chinese top management

With the spin-off of GSK’s consumer health business completed in July, the newly independent Haleon became the largest multinational consumer health company in China. Under a new name totally unfamiliar to Chinese consumers, this “independently launched” company operates a series of well-known health brands in the Chinese market, including Caltrate, Centrum and Sensodyne.

“China is one of Haleon’s top two must-win markets worldwide and our goal in China is to grow faster than the market average.” He Yajun, general manager of Haleon China Nutrition and Health Products Division, told Foodinc today, “In conclusion, our competitive advantage lies in the integration of digital capabilities, technology and human health insights.”

Caltrate is Haleon’s biggest brand in China. When asked about the future opportunities in the nutrition and health sector, she said that this would come from the obvious escalation of Chinese consumers’ health and nutrition needs and active management, and also from the fact that VMS currently has a penetration rate much lower than that in western markets.

发表评论

相关文章